Cerivastatin 0.15μM R05 exp226
Mechanism of Action
Inhibits HMG-CoA reductase, decreases cholesterol biogenesis, upregulates LDL receptors
- Class / Subclass 1: Metabolism / Metabolic Enzyme Inhibitor
Technical Notes
Compound References
- PubChem Name: Cerivastatin sodium
- Synonyms: N/A
- CAS #: 143201-11-0
- PubChem CID: 23663992
- IUPAC: sodium;(E,3R,5S)-7-[4-(4-fluorophenyl)-5-(methoxymethyl)-2,6-di(propan-2-yl)pyridin-3-yl]-3,5-dihydroxyhept-6-enoate
- INCHI Name: InChI=1S/C26H34FNO5.Na/c1-15(2)25-21(11-10-19(29)12-20(30)13-23(31)32)24(17-6-8-18(27)9-7-17)22(14-33-5)26(28-25)16(3)4;/h6-11,15-16,19-20,29-30H,12-14H2,1-5H3,(H,31,32);/q;+1/p-1/b11-10+;/t19-,20-;/m1./s1
- INCHI Key: GPUADMRJQVPIAS-QCVDVZFFSA-M
- Molecular Weight: 481.5
- Canonical SMILES: CC(C)C1=C(C(=C(C(=N1)C(C)C)COC)C2=CC=C(C=C2)F)C=CC(CC(CC(=O)[O-])O)O.[Na+]
- Isomeric SMILES: CC(C)C1=C(C(=C(C(=N1)C(C)C)COC)C2=CC=C(C=C2)F)/C=C/[C@H](C[C@H](CC(=O)[O-])O)O.[Na+]
- Molecular Formula: C26H33FNNaO5
Compound Supplier
- Supplier Name: In house - University of Montreal - Chemistry Platform
- Catalog #: N/A
- Lot #: N/A
Compound Characterization
- HRMS (ESI-TOF) m/z: (M+Na)+ Calcd for C26H35FNO5 483.23915; found 483.2366
Dose Response Curve
- Platform ID: Ceriva
- Min: -2.1969; Max: 88.6305
| IC | Concentration (µM) |
|---|---|
| IC10 | N/A |
| IC20 | 0.0453 |
| IC30 | 0.0841 |
| IC40 | 0.1396 |
| IC50 | 0.2224 |
| IC60 | N/A |
| IC70 | N/A |
| IC80 | N/A |
| IC90 | N/A |
Screen Summary
- Round: 05
- Dose: 150nM
- Days of incubation: 8
- Doublings: 4.5
- Numbers of reads: 25325493
Screen Results
| Sensitive/Resistant hits (FDR<0.05) | CRANKS | Score Plot | Top 30 Genes | Screen Similarity | Top 30 Sensitive GO terms | Top 30 Resistant GO terms |
|---|---|---|---|---|---|---|
| 57/46 | Scores |